Welcome to LookChem.com Sign In|Join Free

CAS

  • or
C76H98O24 is a chemical with a specific purpose. Lookchem provides you with multiple data and supplier information of this chemical.

1383476-32-1 Suppliers

Post Buying Request

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier
  • 1383476-32-1 Structure
  • Basic information

    1. Product Name: C76H98O24
    2. Synonyms: C76H98O24
    3. CAS NO:1383476-32-1
    4. Molecular Formula:
    5. Molecular Weight: 1395.6
    6. EINECS: N/A
    7. Product Categories: N/A
    8. Mol File: 1383476-32-1.mol
  • Chemical Properties

    1. Melting Point: N/A
    2. Boiling Point: N/A
    3. Flash Point: N/A
    4. Appearance: N/A
    5. Density: N/A
    6. Refractive Index: N/A
    7. Storage Temp.: N/A
    8. Solubility: N/A
    9. CAS DataBase Reference: C76H98O24(CAS DataBase Reference)
    10. NIST Chemistry Reference: C76H98O24(1383476-32-1)
    11. EPA Substance Registry System: C76H98O24(1383476-32-1)
  • Safety Data

    1. Hazard Codes: N/A
    2. Statements: N/A
    3. Safety Statements: N/A
    4. WGK Germany:
    5. RTECS:
    6. HazardClass: N/A
    7. PackingGroup: N/A
    8. Hazardous Substances Data: 1383476-32-1(Hazardous Substances Data)

1383476-32-1 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 1383476-32-1 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,3,8,3,4,7 and 6 respectively; the second part has 2 digits, 3 and 2 respectively.
Calculate Digit Verification of CAS Registry Number 1383476-32:
(9*1)+(8*3)+(7*8)+(6*3)+(5*4)+(4*7)+(3*6)+(2*3)+(1*2)=181
181 % 10 = 1
So 1383476-32-1 is a valid CAS Registry Number.

1383476-32-1Downstream Products

1383476-32-1Relevant articles and documents

Structure-activity relationships of saponin derivatives: A series of entry inhibitors for highly pathogenic H5N1 influenza virus

Ding, Ning,Chen, Qing,Zhang, Wei,Ren, Sumei,Guo, Ying,Li, Yingxia

experimental part, p. 316 - 326 (2012/08/08)

The occurrence of highly pathogenic avian influenza virus H5N1 highlights the urgent need for new classes of antiviral drugs. Theoretically, each of steps in influenza viral life cycle can be a target of antiviral therapeutics. However, up to date, no licenced entry inhibitor drug is available for H5N1 or any other influenza viruses. Our strategy for developing new anti-influenza therapeutics is to target the interaction between HA and sialic acid which is influenza viral receptor presented on host cell surface. Here, based on our previously discovered small molecule inhibitor saponin 1, intensive SAR studies around the sugar chain and aglycone were conducted. The results showed that both the chacotriosyl residue and the chlorogenin moiety of active compound 1 are important for the antiviral activity, although several subtle modifications can be made on particular positions.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 1383476-32-1